Deva Holding AS
IST:DEVA.E

Watchlist Manager
Deva Holding AS Logo
Deva Holding AS
IST:DEVA.E
Watchlist
Price: 65 TRY 7.35% Market Closed
Market Cap: 13B TRY

Net Margin
Deva Holding AS

0.6%
Current
21%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.6%
=
Net Income
90.8m
/
Revenue
16.5B

Net Margin Across Competitors

No Stocks Found

Deva Holding AS
Glance View

Market Cap
13B TRY
Industry
Pharmaceuticals

Deva Holding AS engages in the production and marketing of human pharmaceuticals and raw materials. The firm has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company’s product portfolio comprises 73 drugs, which are available on the market in 177 various forms. The company offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The firm has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.

DEVA.E Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.6%
=
Net Income
90.8m
/
Revenue
16.5B
What is the Net Margin of Deva Holding AS?

Based on Deva Holding AS's most recent financial statements, the company has Net Margin of 0.6%.

Back to Top